<p>Mira Pharmaceuticals Inc. has announced the sale of 1,751,000 shares of its common stock to multiple institutional investors through a block sale. The shares were sold at an average price of $2.19 each, representing a 66% premium to the previous day’s closing price. The transaction, facilitated by Rodman &amp; Renshaw via the StockBlock platform, generated gross proceeds of approximately $3.84 million before fees and expenses. No warrants were included in the offering. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mira Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-018303), on October 16, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

MIRA

<p>Mira Pharmaceuticals Inc. has raised $3.84 million by selling 1,751,000 shares at $2.19 each, a 66% premium over the previous closing price. The block sale was facilitated by Rodman & Renshaw through the StockBlock platform, with no warrants included in the offering. This transaction involved multiple institutional investors and was reported on October 16, 2025.</p>

Mira Pharmaceuticals Raises $3.8 Million Through Block Sale of 1.75 Million Shares at 66% Premium